PATENT CLAIM ANALYSIS

Application Number: 15897032
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "001000"]

Abstract:
Methods and compositions are provided for treating hyperproliferative disorders in patients with a PI3K inhibitor, GDC-0032 as a single agent or in combination with chemotherapeutic agents.

Claim (Index 27):
The method of  claim 25  wherein the therapeutic combination is administered by a dosing regimen where the therapeutically effective amount of GDC-0032 is administered in a range from twice daily to once every three weeks, and the therapeutically effective amount of the chemotherapeutic agent is administered in a range from twice daily to once every three weeks.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13912281', '12208227', '12400988', '13109670', '15438277']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.81076518544397
- 35 USC 102 Novelty (BERT): 0.7644454071835731
- Combined Prediction Score: 0.8061332076179304
- Mean Citation Score: 568.5882720000002
- Max Citation Score: 967.9128
- Similarity Product: 883.5604903060913

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test